These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 23101722

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
    Li B, Xie C, Lin X, Su SB.
    Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
    [Abstract] [Full Text] [Related]

  • 3. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.
    Chi W, Yang P, Zhu X, Wang Y, Chen L, Huang X, Liu X.
    Mol Vis; 2010 May 19; 16():880-6. PubMed ID: 20508866
    [Abstract] [Full Text] [Related]

  • 4. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
    Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Jul 19; 49(7):3058-64. PubMed ID: 18579762
    [Abstract] [Full Text] [Related]

  • 5. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
    Takeuchi M, Usui Y, Okunuki Y, Zhang L, Ma J, Yamakawa N, Hattori T, Kezuka T, Sakai J, Goto H.
    Invest Ophthalmol Vis Sci; 2010 Jun 19; 51(6):3067-75. PubMed ID: 20089879
    [Abstract] [Full Text] [Related]

  • 6. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F.
    Clin Exp Rheumatol; 2013 Jun 19; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [Abstract] [Full Text] [Related]

  • 7. Pro-inflammatory cellular immune response in Behçet's disease.
    Kulaber A, Tugal-Tutkun I, Yentür SP, Akman-Demir G, Kaneko F, Gül A, Saruhan-Direskeneli G.
    Rheumatol Int; 2007 Oct 19; 27(12):1113-8. PubMed ID: 17549482
    [Abstract] [Full Text] [Related]

  • 8. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
    Liu X, Yang P, Wang C, Li F, Kijlstra A.
    Rheumatology (Oxford); 2011 Feb 19; 50(2):293-8. PubMed ID: 21059671
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
    Na SY, Park MJ, Park S, Lee ES.
    Clin Exp Rheumatol; 2013 Feb 19; 31(3 Suppl 77):32-40. PubMed ID: 24064012
    [Abstract] [Full Text] [Related]

  • 10. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
    Wang C, Tian Y, Ye Z, Kijlstra A, Zhou Y, Yang P.
    Arthritis Res Ther; 2014 May 28; 16(3):R117. PubMed ID: 24887071
    [Abstract] [Full Text] [Related]

  • 11. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H.
    Immunol Invest; 2017 Jul 28; 46(5):518-525. PubMed ID: 28414558
    [Abstract] [Full Text] [Related]

  • 12. CD4⁺ T cells from behcet patients produce high levels of IL-17.
    Chi W, Zhou S, Yang P, Chen L.
    Eye Sci; 2011 Jun 28; 26(2):65-9. PubMed ID: 21692201
    [Abstract] [Full Text] [Related]

  • 13. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.
    Talaat RM, Sibaii H, Bassyouni IH, El-Wakkad A.
    Eur Cytokine Netw; 2019 Mar 01; 30(1):15-22. PubMed ID: 31122907
    [Abstract] [Full Text] [Related]

  • 14. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease.
    Aridogan BC, Yildirim M, Baysal V, Inaloz HS, Baz K, Kaya S.
    J Dermatol; 2003 Aug 01; 30(8):602-7. PubMed ID: 12928529
    [Abstract] [Full Text] [Related]

  • 15. Cytokine profile in Behçet's disease patients. Relationship with disease activity.
    Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K.
    Scand J Rheumatol; 2002 Aug 01; 31(4):205-10. PubMed ID: 12369651
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.
    Li F, Yang P, Liu X, Wang C, Hou S, Kijlstra A.
    Arch Ophthalmol; 2010 Nov 01; 128(11):1449-54. PubMed ID: 21060047
    [Abstract] [Full Text] [Related]

  • 19. Interferon-γ and nitric oxide production during Behçet uveitis: immunomodulatory effect of interleukin-10.
    Belguendouz H, Messaoudène D, Lahmar K, Ahmedi L, Medjeber O, Hartani D, Lahlou-Boukoffa O, Touil-Boukoffa C.
    J Interferon Cytokine Res; 2011 Sep 01; 31(9):643-51. PubMed ID: 21510811
    [Abstract] [Full Text] [Related]

  • 20. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C, Yucel AA, Yesil TH, Kucuk H, Sezgin B, Mercan R, Yucel AE, Demirel GY.
    Clin Rheumatol; 2018 Oct 01; 37(10):2797-2804. PubMed ID: 29557072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.